Skip to Search Skip to Navigation Skip to Content

Facilities

RCMI Biophotonics Core Facility

Director: Colleen Witt, Ph.D.
The RCMI Biophotonics Core Facility provides cutting edge technology for the study and manipulation of biological samples using light, including long-term in-depth imaging of live tissues and the technology to probe at the molecular level for protein-protein interactions within live samples.

RCMI Computational Systems Biology Core Facility

Director: Zhiwei Wang, MCS
The RCMI Computational Systems Biology Core Facility provides computational support for basic and translational health research, including computational infrastructure to support modeling and simulation of biological systems, live cell imaging, and protein biomarker research. The facility provides hardware, software, and programming scripting support, as well as computational research expertise.

RCMI Nanotechnology and Human Health Core Facility

Director: Miguel Jose-Yacaman, Ph.D.
The RCMI Nanotechnology and Human Health Core Facility focuses on the synthesis and characterization of nanomaterials for imaging, labels for bioassays, and active targeting for in vivo or in vitro diagnostics. The Core studies the interaction of nanoparticles with living cells for application in the targeted delivery of drugs, genes, and proteins; tissue engineering scaffolds; artificial organs and implants; and bioimaging and cell labeling.

RCMI Proteomics and Protein Biomarkers Core Facility

Director: Will Haskins, Ph.D.
The RCMI Proteomics and Protein Biomarkers Core Facility is focused on capillary liquid chromatography-mass spectrometry (LC/MS) and -tandem mass spectrometry (LC/MS/MS) to identify, characterize, and quantify proteins. The Proteomics Core develops novel methods, while the Protein Biomarkers Core applies these methods to discover and validate novel protein biomarkers of disease.